EVRALENT
Glaxo Group Limited
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79263054 |
| Registration Number | 5974602 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Merilee J. Arevalo |
| Attorney Docket Number | 82777038 |
| Law Office Assigned | N10 |
| Employee Name | ZAK, HENRY S |
Timeline
| 2019-05-16 | Application Filed |
| 2019-10-11 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-10-11 | Status: Live/Pending |
| 2019-11-16 | Transaction Date |
| 2019-11-19 | Published for Opposition |
| 2020-02-04 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Glaxo Group Limited |
| Entity Statement | Registered Company |
| Address | 980 Great West Road Brentford, Middlesex TW8 9GS GB GB8 |
| Legal Entity Type | |
| Legal Entity State | GB8 |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines |
| GS0051 | Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2019-07-18 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-07-19 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2019-07-23 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2019-08-01 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2019-08-02 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2019-08-03 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2019-08-27 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2019-08-27 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2019-09-13 | 9 RFNP P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-10-02 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-10-02 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-10-04 | 12 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-10-08 | 13 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2019-10-10 | 14 ALIE A:Allowance for Publication |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-10-30 | 15 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2019-10-30 | 16 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2019-10-30 | 17 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2019-11-16 | 18 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2019-11-19 | 19 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-11-19 | 20 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2020-02-04 | 21 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2020-05-04 | 22 FICR P: |
| FINAL DISPOSITION PROCESSED | 2020-05-15 | 23 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2020-05-15 | 24 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2020-06-05 | 25 FINO P: |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2023-07-28 | 26 ADCH M: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 